|
|
|
Volumn 54, Issue 1386, 2012, Pages 21-23
|
|
Extended-release exenatide (Bydureon) for type 2 diabetes.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
EXENDIN 4;
GLUCAGON LIKE PEPTIDE RECEPTOR;
GLUCAGON RECEPTOR;
GLUCAGON-LIKE PEPTIDE RECEPTOR;
PEPTIDE;
VENOM;
ARTICLE;
CLINICAL TRIAL (TOPIC);
DELAYED RELEASE FORMULATION;
DRUG ADMINISTRATION;
DRUG POTENTIATION;
HUMAN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATHOPHYSIOLOGY;
CLINICAL TRIALS AS TOPIC;
DELAYED-ACTION PREPARATIONS;
DIABETES MELLITUS, TYPE 2;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
HYPOGLYCEMIC AGENTS;
PEPTIDES;
RECEPTORS, GLUCAGON;
VENOMS;
|
|
EID: 84860555259
PISSN: None
EISSN: 15232859
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|